Pharmacy benefit managers : current legal framework /

Issues in designing a prescription drug benefit for Medicare.
Published: (2002)

Medicare prescription drug benefit : hearing before the Committee on Finance, United States Senate, One Hundred Sixth Congress, first session, June 23, 1999.
Published: (1999)

Medicare prescription drug benefit : review and oversight : hearing before the Committee on Finance, United States Senate, One Hundred Tenth Congress, first session, May 8, 2007.
Published: (2007)

Medicare prescription drug benefit : review and oversight : hearing before the Committee on Finance, United States Senate, One Hundred Tenth Congress, first session, May 8, 2007.
Published: (2007)

Litigation continues over use of contract pharmacies in 340B Drug Discount Program /
by: Rogers, Hannah-Alise
Published: (2024)

Bringing transparency and accountability to pharmacy benefit managers : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Eighteenth Congress, first session, February 16, 2023.
Published: (2024)

Implementation of the Medicare drug benefit : hearing before the Subcommittee on Health of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Ninth Congress, second session,May 3 and May 4, 2006.
Published: (2011)

The top five outpatient prescription drugs ranked by total expense for children, adults, and the elderly, 2004 /
by: Stagnitti, Marie N.
Published: (2007)

The demand for prescription drugs as a function of cost-sharing /
by: Leibowitz, Arleen A.
Published: (1985)

Coverage of outpatient prescription drugs under Medicare part B : hearings before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundredth Congress, first session, April 23 and June 2, 1987.
Published: (1988)

Pharmacy benefit managers : early results on ventures with drug manufacturers : report to the Honorable Ron Wyden, House of Representatives /
Published: (1995)

Prescription drugs : modernizing Medicare for the 21st century : hearing before ... 106th Congress, 2nd session, June 14, 2000.
Published: (2000)

The politics of the international pricing of prescription drugs /
by: Harrison, Christopher Scott
Published: (2004)

The role of pharmacy benefit managers in prescription drug markets : report prepared by the House Committee on Oversight and Accountability staff.
Published: (2024)

Third party prepaid prescription programs : hearings, Ninety-second Congress, first session, pursuant to H. Res. 5 and 19 ... July 7, 8, and 9, 1971.
Published: (1971)

A detailed description of CBO's cost estimate for the Medicare prescription drug benefit.
Published: (2004)

The role of pharmacy benefit managers in prescription drug markets : hearing before the Committee on Oversight and Accountability, House of Representatives, One Hundred Eighteenth Congress, first session.
Published: (2023)

Reimbursement and access to prescription drugs under Medicare part B : hearing before the Subcommittee on Health Care of the Committee on Finance, United States Senate, One Hundred Seventh Congress, second session, March 14, 2002.
Published: (2002)

Effects of using generic drugs on Medicare's prescription drug spending.
by: Somers, Julie
Published: (2010)

Constitutional challenges to the medicare drug price negotiation program /
by: Rogers, Hannah-Alise
Published: (2023)

Medicaid prescription drugs : CMS should implement revised federal upper limits and monitor their relationship to retail pharmacy acquisition costs : report to congressional requesters.
Published: (2013)

Public attitudes toward prescription costs and the drug industry : a report /
Published: (1955)

Medicare payments for currently covered prescription drugs : hearing before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundred Seventh Congress, second session, October 3, 2002.
Published: (2003)

Medicare payments for currently covered prescription drugs : hearing before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundred Seventh Congress, second session, October 3, 2002.
Published: (2003)

The role of pharmacy benefits managers in prescription drug markets : hearing before the Committee on Oversight and Accountability, U.S. House of Representatives, One Hundred Eighteenth Congress, second session.
Published: (2024)

Pay-for-delay : how drug company pay-offs cost consumers billions : an FTC staff study.
Published: (2010)

Drug pricing : manufacturer discounts in the 340B program offer benefits, but federal oversight needs improvement : report to congressional committees.
Published: (2011)

Prescription drug price increases : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first session, July 15, 1985.
Published: (1986)

Effects of medicare's drug pricing on other purchasers.
Published: (2007)

The big fix : how the pharmaceutical industry rips off American consumers /
by: Greider, Katharine
Published: (2003)

Lowering prescription drug prices : deconstructing the drug supply chain : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, May 9, 2019.
Published: (2021)

Competition in prescription drug markets, 2017-2022 /
by: Parasrampuria, Sonal, et al.
Published: (2023)

The Drug manufacturing industry : a prescription for profits : staff report of the Special Committee on Aging, United States Senate.
Published: (1991)

Internet pharmacy and drug importation : exploring risks and benefits : hearing before the Special Committee on Aging, United States Senate, One Hundred Ninth Congress, first session, Washington, DC, January 26, 2005.
Published: (2005)

Internet pharmacy and drug importation : exploring risks and benefits : hearing before the Special Committee on Aging, United States Senate, One Hundred Ninth Congress, first session, Washington, DC, January 26, 2005.
Published: (2005)

Persistence in Medicare prescription drug expenditures by treatment class /
by: Banthin, Jessica S.
Published: (2006)